Citation only
via OpenAlex
Sarcopenia and hypertrophy in aged skeletal muscle is independent of lifelong muscle stem cell depletion
Jonah Dan Lee, Jyothi Mula, Christopher S. Fry, Tyler J. Kirby, Janna Renee Jackson, Jake A. Beggs, Marilyn S. Campbell, Tyler E Kmiec, Esther E. Dupont‐Versteegden, John Joseph McCarthy, Charlotte A. Peterson
The FASEB Journal · 2013 · ▲ 1 citations
Abstract
Unresolved questions in aged muscle involve whether the loss of muscle stem cells, satellite cells, contributes to sarcopenia and impedes hypertrophy of aged muscle. To directly address these questions, we developed the Pax7‐DTA mouse that conditionally and specifically ablates Pax7+ satellite cells following tamoxifen administration (TM). Four month old mice were treated with TM or vehicle and at 5 (young) or 24 (old) months of age were subjected to a synergist ablation (SA; two weeks of overload) or sham surgery. With age, vehicle treated muscles demonstrated a 52% reduction in Pax7+ satellite cells. TM treated muscles showed >;90% ablation after 1 month and no recovery after 20 months, such that the aged mice lived the majority of their lives with a significantly reduced satellite cell pool. Despite Pax7 depletion with TM, muscle mass, fiber cross‐sectional area and function were all reduced with age independent of Pax7 number. After SA, TM mice increased muscle mass and fiber cross‐sectional area to the same extent as vehicle, with old mice demonstrating an attenuated hypertrophy compared to young. Large myofiber distribution decreased with age and increased with SA, independent of Pax7 number. However, the total number of small fibers (<600 um 2 ), relatively more abundant in aged muscle, were reduced with TM. These data provide convincing evidence the satellite cell niche does not play a role in maintenance of skeletal muscle mass across the lifespan or in hypertrophy of young or old muscle. Funding: NIH R01AR060701, R21AG34453. Ellison Foundation/American Federation of Aging Research EPD12102.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1096/fasebj.27.1_supplement.1150.8
- Canonical
- link ↗
- Fetched
- 2026-10-17 MST
Cite this
APA
Lee, J.D., Mula, J., Fry, C.S., Kirby, T.J., Jackson, J.R., Beggs, J.A., Campbell, M.S., Kmiec, T.E., Dupont‐Versteegden, E.E., McCarthy, J.J., & Peterson, C.A. (2013). Sarcopenia and hypertrophy in aged skeletal muscle is independent of lifelong muscle stem cell depletion. <em>The FASEB Journal</em>. https://doi.org/10.1096/fasebj.27.1_supplement.1150.8
Vancouver
Lee JD, Mula J, Fry CS, Kirby TJ, Jackson JR, Beggs JA, et al. Sarcopenia and hypertrophy in aged skeletal muscle is independent of lifelong muscle stem cell depletion. The FASEB Journal. 2013. doi:10.1096/fasebj.27.1_supplement.1150.8.
BibTeX
@article{jonah2013Sarcop,
title = {Sarcopenia and hypertrophy in aged skeletal muscle is independent of lifelong muscle stem cell depletion},
author = {Jonah Dan Lee and Jyothi Mula and Christopher S. Fry and Tyler J. Kirby and Janna Renee Jackson and Jake A. Beggs and Marilyn S. Campbell and Tyler E Kmiec and Esther E. Dupont‐Versteegden and John Joseph McCarthy and Charlotte A. Peterson},
journal = {The FASEB Journal},
year = {2013},
doi = {10.1096/fasebj.27.1_supplement.1150.8},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging Cell 2008
Open access · OA
Stem Cell Review Series: Aging of the skeletal muscle stem cell niche
Journal of Cellular Physiology 2006
Citation only
Prolonged absence of myostatin reduces sarcopenia
Mechanisms of Ageing and Development 2020
Open access · CC-BY
Skeletal muscle aging – Stem cells in the spotlight
The Indonesian Biomedical Journal 2015
Open access · CC-BY
Molecular Regulation and Rejuvenation of Muscle Stem (Satellite) Cell Aging
Molecular Therapy 2007
Open access · CC-BY
Antagonism of Myostatin Enhances Muscle Regeneration During Sarcopenia
The FASEB Journal 2018
Preprint · OA